Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Spring Seed Grant 2025 in partnership with Patients Associations – Call for Applications

Fondazione Telethon

The Spring Seed Grant 2025 initiative, in partneship with Patients Associations, is now open. The initiative aims to fund seed research projects through 4 single-center calls, for 12-month proposals with a maximum budget of € 50.000, focusing on the following rare genetic diseases:

Anderson-Fabry Disease (AFD)
SATB2-associated Syndrome (SATB2)
Sturge-Weber Syndrome (STUWE)
Jamuar Syndrome or UGDH-related disorder (UGDH)

For these monothematic calls, Fondazione Telethon established a collaboration agreement with the following Patients Associations:

Associazione Italiana Anderson-Fabry
Associazione SATB2 Italia
Associazione Sindrome Sturge-Weber Italia
Associazione UGDH Italia – Il sorriso di Aurora

These calls will allow the generation of data and the creation of new knowledge to pave the road for the development of new therapeutic approaches for rare genetic diseases.

Investigators - working either in public or private Italian non-profit research Institutions, including the Fondazione Telethon Institutes (SR-TIGET and TIGEM) are eligible regardless of their funding status with Fondazione Telethon ETS.

Applicants can submit only one project within the Spring Seed Grant 2025 initiative, as Lead Applicant.

All the documents related to the Spring Seed Grant 2025 calls are listed below and accessible through the links or on the Fondazione Telethon Grant Management System portal at this link.

Calls Deadlines

April 1st, 2025: calls opening

by April 15th, 2025 applicants should:

login or register on the Fondazione Telethon Grant Management System portal at this link
insert the title of the project
fill in the Type of Research section, providing the disease name and code, research type and research step

Filling in these data by April 15th 2025 is not mandatory.

May 6th, 2025, at 1 pm: project submission deadline.

Specialties

Genetics & Genomics

Others

Neurosciences

Public Health

Eligibility Requirements

focusing on the following rare genetic diseases:

Anderson-Fabry Disease (AFD)
SATB2-associated Syndrome (SATB2)
Sturge-Weber Syndrome (STUWE)
Jamuar Syndrome or UGDH-related disorder (UGDH)

Eligible Countries:

Italy

Sponsor Details

Sponsor Institute/Organizations: Fondazione Telethon

Sponsor Type: Corporate

Address: Via Varese 16b - 00185 Roma Tel. +39 06 440151 Fax. +39 06 44 015521

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity